Hexo Corp (HEXO)
$0.72 0.03 (4.49%)
10:08 EDT HEXO Stock Quote Delayed 20 Minutes
Previous Close $0.69
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 680,837
Day's Range 0.72 - 0.76
52-Week Range 0.35 - 8.40
Dividend & Yield N/A (N/A)
HEXO Stock Predictions, Articles, and Hexo Corp News
- From InvestorPlace
- From the Web
Hexo (HEXO) earnings for the Canadian cannabis company's fiscal second quarter of 2020 have HEXO stock taking a beating on Monday.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
While markets may roar to all-time highs in 2020, these five stocks likely will miss the party and are stocks to sell in the new year.
Hexo stock continues to fall, making new lows while its peers have so far refrained. Avoid Hexo as a result.
Hexo stock has fallen just over 80% as it waits for Cannabis 2.0 to take root. However, after a year of overpromising, investors' patience is thin.
Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.
With Cannabis 2.0 in the works, Hexo’s risk-reward profile is beginning to look very favorable for investors willing to stick their necks out. Here’s why.
Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.
Hexo has significant growth and balance sheet problems. A strong Q1 report won't fix those issues, but could inspire confidence in a turnaround.
At the end of the day, the cannabis industry will birth only 5 to 10 big winners, and HEXO stock likely won't be one of them.
By David Moadel
I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
By Thomas Niel
Hexo stock is a falling knife. But the rollout of a discount dried flower product and infused beverages could mean more "dead cat bounces."
Like many of its marijuana peers, Hexo stock gave investors a terrible earnings report this quarter. And things aren't getting better anytime soon.
Charles Schwab to purchase TD Ameritrade? Let's look at all of the M&A news making noise in the stock market today.
As HEXO stock has overpromised and underdelivered in recent months. the Hexo stock price has declined very rapidly.
Hexo stock finds itself in a unique position in that it has more credibility than a typical small cannabis firm but isn’t quite big enough to challenge the alpha dogs. Thus, HEXO is a perfect buyout target.
From Real Money
Navellier RatingsPowered by Portfolio Grader